Cargando…

Combination of vedolizumab and immunomodulators in ulcerative colitis

Detalles Bibliográficos
Autor principal: Pinton, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290656/
https://www.ncbi.nlm.nih.gov/pubmed/34519096
http://dx.doi.org/10.1111/jgh.15686
_version_ 1784748954084179968
author Pinton, P
author_facet Pinton, P
author_sort Pinton, P
collection PubMed
description
format Online
Article
Text
id pubmed-9290656
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-92906562022-07-20 Combination of vedolizumab and immunomodulators in ulcerative colitis Pinton, P J Gastroenterol Hepatol Letters to the Editor John Wiley and Sons Inc. 2021-09-22 2021-12 /pmc/articles/PMC9290656/ /pubmed/34519096 http://dx.doi.org/10.1111/jgh.15686 Text en © 2021 The Authors. Journal of Gastroenterology and Hepatology published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Letters to the Editor
Pinton, P
Combination of vedolizumab and immunomodulators in ulcerative colitis
title Combination of vedolizumab and immunomodulators in ulcerative colitis
title_full Combination of vedolizumab and immunomodulators in ulcerative colitis
title_fullStr Combination of vedolizumab and immunomodulators in ulcerative colitis
title_full_unstemmed Combination of vedolizumab and immunomodulators in ulcerative colitis
title_short Combination of vedolizumab and immunomodulators in ulcerative colitis
title_sort combination of vedolizumab and immunomodulators in ulcerative colitis
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290656/
https://www.ncbi.nlm.nih.gov/pubmed/34519096
http://dx.doi.org/10.1111/jgh.15686
work_keys_str_mv AT pintonp combinationofvedolizumabandimmunomodulatorsinulcerativecolitis